AIT is the only therapeutic class capable of modifying the disease progression and potentially preventing the onset of the disease by inducing tolerance in the immune system ^{(source: Global Atlas of Allergy, EAACI 2014)}.

As part of our commitment to help patients live life beyond allergy, we offer a broad portfolio of allergen extracts and a wide range of state-of-the-art therapeutic solutions for children and adults which provide long lasting relief from the burden of allergies.

Spanning source materials, routes of administration, cutting-edge delivery mechanisms and finished products, ours is an innovative portfolio of therapeutic solutions designed to improve ease of access and treatment outcomes*.

Whatever the options, all of our AIT treatments meet the most stringent clinical criteria as well as health authorities’ regulatory requirements. 

*not all products are manufactured in all regions

Learn more about our approach to allergen immunotherapy